secwatch.observer — SEC 8-K summary
======================================

Issuer:     RxSight, Inc. (RXST)
CIK:        0001111485
Form:       8-K
Filed at:   2024-05-09T23:59:59+00:00
Accession:  0001193125-24-135328
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RxSight prices $100M public stock offering at $56/share for commercial expansion
--------------------------------------------------------------------------------

- Offering of 1,785,714 shares at $56/share; underwriters have 30-day option for 267,857 additional shares.
- Net proceeds expected ~$93.2M after underwriting discount and estimated offering expenses.
- Proceeds to fund commercial/marketing expansion (including international), product development, R&D, and working capital.
- Offering expected to close May 13, 2024, subject to customary closing conditions.
- Directors and executive officers subject to 60-day lock-up restrictions on their shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1111485/000119312524135328/0001193125-24-135328-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1111485/000119312524135328/d832746d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-135328

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer